Publicaciones en las que colabora con Francisco Javier Pavón Morón (52)

2023

  1. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

2022

  1. Niveles plasmáticos de midkina en pacientes con trastorno por uso de cocaína en abstinencia

    Adicciones: Revista de socidrogalcohol, Vol. 34, Núm. 4, pp. 273-277

2021

  1. Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking

    Addiction Biology, Vol. 26, Núm. 3

  2. Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder

    Scientific Reports, Vol. 11, Núm. 1

  3. Inflammatory factors and depression in substance use disorder

    The Neuroscience of Depression: Genetics, Cell Biology, Neurology, Behavior, and Diet (Elsevier), pp. 149-160

  4. Inflammatory factors and depression in substance use disorder

    The Neuroscience of Depression, 1st Edition: Volume 1-2 (Elsevier), pp. V2-149-V2-160

  5. Influence of gender and education on cocaine users in an outpatient cohort in Spain

    Scientific Reports, Vol. 11, Núm. 1

  6. Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder

    Scientific Reports, Vol. 11, Núm. 1

  7. Plasma concentrations of lysophosphatidic acid and autotaxin in abstinent patients with alcohol use disorder and comorbid liver disease

    Biomedicines, Vol. 9, Núm. 9

  8. Sex-specific behavioral and neurogenic responses to cocaine in mice lacking and blocking dopamine D1 or dopamine D2 receptors

    Journal of Comparative Neurology, Vol. 529, Núm. 8, pp. 1724-1742

  9. Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brain

    Brain Structure and Function, Vol. 226, Núm. 7, pp. 2243-2264

2020

  1. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260

  2. Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1β

    Neuropharmacology, Vol. 162

  3. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102

  4. Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients

    Scientific Reports, Vol. 10, Núm. 1

  5. Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats

    Addiction Biology, Vol. 24, Núm. 5, pp. 1019-1033

  2. Bupropion, a possible antidepressant without negative effects on alcohol relapse

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 756-765

  3. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders

    PLoS ONE, Vol. 14, Núm. 3

  4. Oleoylethanolamide modulates BDNF-ERK signaling and neurogenesis in the hippocampi of rats exposed to δ9-THC and ethanol binge drinking during adolescence

    Frontiers in Molecular Neuroscience, Vol. 12